116 related articles for article (PubMed ID: 19020649)
1. Anterior uveitis associated with fixed-combination latanoprost and timolol.
Ornek K; Onaran Z; Turgut Y
Can J Ophthalmol; 2008 Dec; 43(6):727-8. PubMed ID: 19020649
[No Abstract] [Full Text] [Related]
2. Five-year, multicenter safety study of fixed-combination latanoprost/timolol (Xalacom) for open-angle glaucoma and ocular hypertension.
Alm A; Grunden JW; Kwok KK
J Glaucoma; 2011; 20(4):215-22. PubMed ID: 20520568
[TBL] [Abstract][Full Text] [Related]
3. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
Higginbotham EJ; Olander KW; Kim EE; Grunden JW; Kwok KK; Tressler CS;
Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma.
Konstas AG; Kozobolis VP; Tersis I; Leech J; Stewart WC
Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169
[TBL] [Abstract][Full Text] [Related]
5. Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
Cvenkel B; Stewart JA; Nelson LA; Stewart WC
Curr Eye Res; 2008 Feb; 33(2):163-8. PubMed ID: 18293187
[TBL] [Abstract][Full Text] [Related]
6. Suspected granulomatous anterior uveitis associated with brimonidine tartrate 0.2% and timolol maleate 0.5% ophthalmic solution.
Casado A; Cabarga C; de la Fuente MA; Muñoz-Negrete FJ
Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2659-60. PubMed ID: 23835755
[No Abstract] [Full Text] [Related]
7. Bilateral poliosis and granulomatous anterior uveitis associated with latanoprost use and apparent hypotrichosis on its withdrawal.
Waheed K; Laganowski H
Eye (Lond); 2001 Jun; 15(Pt 3):347-9. PubMed ID: 11450742
[No Abstract] [Full Text] [Related]
8. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
[TBL] [Abstract][Full Text] [Related]
9. Ocular complications of latanoprost in uveitic glaucoma: three case reports.
Saccà S; Pascotto A; Siniscalchi C; Rolando M
J Ocul Pharmacol Ther; 2001 Apr; 17(2):107-13. PubMed ID: 11324978
[TBL] [Abstract][Full Text] [Related]
10. The combination latanoprost-timolol versus twice daily 0.50% timolol administration either associated or not with latanoprost: efficacy and tolerability in the primary open-angle glaucoma.
Pacella E; Pacella F; Cavallotti C; Librando A; Feher J; Pecori-Giraldi J
Eur Rev Med Pharmacol Sci; 2010 May; 14(5):477-80. PubMed ID: 20556928
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy.
Konstas AG; Boboridis K; Tzetzi D; Kallinderis K; Jenkins JN; Stewart WC
Arch Ophthalmol; 2005 Jul; 123(7):898-902. PubMed ID: 16009829
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma.
Pajic B; Pajic-Eggspuehler B; Häfliger IO
Curr Med Res Opin; 2010 Sep; 26(9):2213-9. PubMed ID: 20673200
[TBL] [Abstract][Full Text] [Related]
13. Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.
Konstas AG; Mikropoulos D; Dimopoulos AT; Moumtzis G; Nelson LA; Stewart WC
Br J Ophthalmol; 2008 Nov; 92(11):1498-502. PubMed ID: 18703549
[TBL] [Abstract][Full Text] [Related]
14. Intraocular pressure and safety in glaucoma patients switching to latanoprost/timolol maleate fixed combination from mono- and adjunctive therapies.
Konstas AG; Bányai L; Blask KD; Väth J; Kozobolis VP; Trüb PR; Tsironi S; Maloutas S; Teus MA; Stewart WC
J Ocul Pharmacol Ther; 2004 Oct; 20(5):375-82. PubMed ID: 15650512
[TBL] [Abstract][Full Text] [Related]
15. Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies.
Hamacher T; Schinzel M; Schölzel-Klatt A; Neff HM; Maier H; Schlaffer G; Beausencourt E; Jütte M; Scholz R; Lorger C; Stewart WC
Br J Ophthalmol; 2004 Oct; 88(10):1295-8. PubMed ID: 15377554
[TBL] [Abstract][Full Text] [Related]
16. A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components.
Diestelhorst M; Larsson LI;
Ophthalmology; 2006 Jan; 113(1):70-6. PubMed ID: 16263174
[TBL] [Abstract][Full Text] [Related]
17. 24-Hour control with a latanoprost-timolol fixed combination vs timolol alone.
Konstas AG; Lake S; Economou AI; Kaltsos K; Jenkins JN; Stewart WC
Arch Ophthalmol; 2006 Nov; 124(11):1553-7. PubMed ID: 17102001
[TBL] [Abstract][Full Text] [Related]
18. Bimatoprost/timolol fixed combination vs latanoprost/timolol fixed combination in open-angle glaucoma patients.
Martinez A; Sanchez M
Eye (Lond); 2009 Apr; 23(4):810-8. PubMed ID: 18535605
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment.
Konstas AG; Kozobolis VP; Tsironi S; Makridaki I; Efremova R; Stewart WC
Ophthalmology; 2008 Jan; 115(1):99-103. PubMed ID: 18166407
[TBL] [Abstract][Full Text] [Related]
20. Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%.
Konstas AG; Kozobolis VP; Lallos N; Christodoulakis E; Stewart JA; Stewart WC
Eye (Lond); 2004 Dec; 18(12):1264-9. PubMed ID: 15218522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
